NFAT Luciferase Reporter Jurkat Cell Line from BPS Bioscience, Inc.

Product Specs
ItemNFAT Luciferase Reporter Jurkat Cell Line
CompanyBPS Bioscience, Inc.
Price $2,525.00Supplier Page View Company Product Page
Catalog Number60621
Quantity2 vials
ApplicationsMonitor intracellular calcium levels., Screen for activators or inhibitors of PKC/ Ca2+ pathway., Screen for agonists or antagonists of T cell receptors., Control for immune checkpoint NFAT reporter cell lines
TypeCell Line
Cell LineJurkat
Source/Expression Systemhuman
Jurkat

Add to Compare List

BPS Bioscience, Inc.

6405 Mira Mesa Blvd

Suite 100

San Diego, CA 92121

United States

Phone: 858-202-1401

Email: sales-team@bpsbioscience.com

Company Profile

Website: https://bpsbioscience.com/

(1) Second generation CD2-targeting LFA-3 fusion protein SBT115301 to restore immune homeostasis in autoimmune diseaseiScienceMay 16, 2025Herve Lebrec, John Bui, Jonathan M. Clingan, Jason Do, Jason Dubovsky, Leonard Dragone, Ekaterina Gibiansky, Wing Yu Lam, Katherine Matsuda, Lauren Mihalcik, et al.lines,Experimental models: Cell lines ,, NFAT Luciferase Reporter Jurkat Cell Line,BPS Bioscience,Cat#60621 ,, Software and algorithms,Software and algorithms,Software and algorithms ,, Prism v10.4.1,GraphPad, Phoenix

(2) Multi-targeted, NOT gated CAR-T cells as a strategy to protect normal lineages for blood cancer therapyFrontiers in ImmunologyMarch 21, 2025Breanna DiAndreth, Pavlo A. Nesterenko, Aaron G. Winters, Aaron D. Flynn, Claudia A. Jette, Vasantika Suryawanshi, Sanam Shafaattalab, Sara Martire, Mark Daris, Elizabeth Moore, et al.for the NFAT-firefly luciferase reporter Jurkat cell line that was purchased from BPS bioscience (#60621). K562 cells were maintained in RPMI supplemented with 10% heat inactivated FBS and 1% penicillin-streptomycin.

(3) Potent, Selective CARs as Potential T-Cell Therapeutics for HPV-positive CancersJournal of ImmunotherapyOctober 1, 2021Xueyin Wang et al.were purchased from ATCC. Jurkat NFAT-firefly luciferase cells were purchased from BPS Bioscience (#60621). When needed, green fluorescent protein (GFP) was stably expressed in A375 and CaSki cells using lentivirus

(4) Re-examination of MAGE-A3 as a T-cell Therapeutic TargetJournal of ImmunotherapyApril 1, 2021Aaron D. Martin et al.purchased from JCRB Cell Bank. Jurkat NFAT-Firefly-Luciferase cells were purchased from BPS Bioscience (#60621). All cell lines were cultured in media as recommended by the vendors. A 100 U/mL penicillin-streptomycin

(5) KIR3DL3 Is an Inhibitory Receptor for HHLA2 that Mediates an Alternative Immunoinhibitory Pathway to PD1Cancer immunology researchFebruary 1, 2021Bhatt RS, Berjis A, Konge JC, Mahoney KM, Klee AN, Freeman SS, Chen CH, Jegede OA, Catalano PJ, Pignon JC, et al.anti-CD3 scFV (BPS Bioscience 60539), Jurkat cells expressing the NFAT reporter (Luc) (BPS Bioscience 60621) and Jurkat cells expressing IL2 reporter (Luc) (BPS Bioscience 60481) were purchased from BPS Bioscience

(6) A T cell redirection platform for co-targeting dual antigens on solid tumorsmAbsJanuary 1, 2021Enderle L, Shalaby KH, Gorelik M, Weiss A, Blazer LL, Paduch M, Cardarelli L, Kossiakoff A, Adams JJ, Sidhu SS.RPMI medium (ATCC formulation), containing DATEs and 100,000 Jurkat NFAT-luc cells (BPS Bioscience # 60621) per well. After 24 h, NFAT reporter activation was assessed by measuring the remaining luciferase activity

(7) A multivariate, quantitative assay that disentangles key kinetic parameters of primary human T cell function in vitroPloS oneJanuary 1, 2020Huang GL, Nampe DP, Yi J, Gabrelow GB, Negri KR, Kamb A, Xu H.with 10% fetal bovine serum. Jurkat NFAT-Firefly-Luciferase cells were purchased from BPS Biosicence (60621) and were cultured in RPMI1640 (Gibco 72400–047) supplemented with 10% heat-inactivated fetal bovine

Be the First to Write a Review!